Anebulo Pharmaceuticals Inc (ANEB) — Financial Flexibility Index
Anebulo Pharmaceuticals Inc (ANEB) has a Financial Flexibility Index of -0.88x as of December 2025. Free cash flow of $-1.31 Million (operating CF $-1.31 Million minus capex $0.00) represents -1% of total liabilities ($1.49 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anebulo Pharmaceuticals Inc Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Anebulo Pharmaceuticals Inc across 6 annual periods. See ANEB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Anebulo Pharmaceuticals Inc (2020–2025)
Year-by-year free cash flow to debt coverage for Anebulo Pharmaceuticals Inc. For the full company profile including market capitalisation, see Anebulo Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.02x | $-6.35 Million | $-6.35 Million | $487.69K | ▲ +58.1% |
| 2024 | -31.05x | $-8.09 Million | $-8.09 Million | $260.58K | ▼ -242.7% |
| 2023 | -9.06x | $-9.68 Million | $-9.68 Million | $1.07 Million | ▲ +14.6% |
| 2022 | -10.61x | $-5.44 Million | $-5.44 Million | $512.53K | ▲ +47.4% |
| 2021 | -20.16x | $-4.87 Million | $-4.87 Million | $241.63K | ▼ -2893.3% |
| 2020 | -0.67x | $-150.77K | $-150.77K | $223.87K | — |